1. Home
  2. BDSX vs ZYXI Comparison

BDSX vs ZYXI Comparison

Compare BDSX & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$6.60

Market Cap

62.5M

Sector

Health Care

ML Signal

HOLD

Logo Zynex Inc.

ZYXI

Zynex Inc.

HOLD

Current Price

$0.13

Market Cap

35.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDSX
ZYXI
Founded
2005
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
62.5M
35.8M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
BDSX
ZYXI
Price
$6.60
$0.13
Analyst Decision
Strong Buy
Hold
Analyst Count
5
3
Target Price
$32.50
$3.00
AVG Volume (30 Days)
66.9K
10.5M
Earning Date
11-03-2025
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$80,173,000.00
$108,202,000.00
Revenue This Year
$20.75
N/A
Revenue Next Year
$25.05
$9.30
P/E Ratio
N/A
N/A
Revenue Growth
22.29
N/A
52 Week Low
$3.44
$0.12
52 Week High
$31.20
$8.45

Technical Indicators

Market Signals
Indicator
BDSX
ZYXI
Relative Strength Index (RSI) 42.36 30.05
Support Level $6.30 $0.23
Resistance Level $7.03 $0.35
Average True Range (ATR) 0.65 0.13
MACD -0.17 -0.07
Stochastic Oscillator 21.76 0.99

Price Performance

Historical Comparison
BDSX
ZYXI

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About ZYXI Zynex Inc.

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.

Share on Social Networks: